Published on 16 Oct 2024 on Bloomberg · via Yahoo Finance
(Bloomberg) -- Companies developing RNA-editing therapies rallied on Wednesday after breakthrough data from a clinical trial showed the technology’s promise as a treatment.
Most Read from Bloomberg
Inside the ‘Utopias’ of Mexico CityHow Mexico City Averted All-Out DroughtOne City’s Plan to Re-Link a Neighborhood That Robert Moses DividedChicago Should Consider Furloughs, Higher Booze Tax, Watchdog SaysMexico Seeks to Halve Permitting Time to Attract More Factories